Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6216]

KRAS G12C inhibitor sotorasib receives conditional marketing authorisation by MHRA for use in Great Britain

KRAS G12C inhibitor sotorasib receives conditional marketing authorisation by MHRA for use in Great Britain

Six-month efficacy of Pfizer/BioNTech COVID-19 vaccine in patients with solid tumours similar to general population

Six-month efficacy of Pfizer/BioNTech COVID-19 vaccine in patients with solid tumours similar to general population

FDA approves zanubrutinib for Waldenström’s macroglobulinemia

FDA approves zanubrutinib for Waldenström’s macroglobulinemia

Antibiotics increase the risk of colon cancer

Antibiotics increase the risk of colon cancer

Chemotherapy plus immunotherapy before surgery is beneficial for invasive bladder cancer outcomes

Chemotherapy plus immunotherapy before surgery is beneficial for invasive bladder cancer outcomes

When less is more: A modified chemotherapy regimen for a rare type of lymphoma

When less is more: A modified chemotherapy regimen for a rare type of lymphoma

Dual-action breast cancer compounds aim to overcome common drug-resistance issues

Dual-action breast cancer compounds aim to overcome common drug-resistance issues

Jury still out on cardiovascular safety of prostate cancer treatments

Jury still out on cardiovascular safety of prostate cancer treatments

A cost-effective anti-angiogenic drug to treat lung cancer is finally here

A cost-effective anti-angiogenic drug to treat lung cancer is finally here

FDA approves ivosidenib for advanced or metastatic cholangiocarcinoma

FDA approves ivosidenib for advanced or metastatic cholangiocarcinoma

More from ecancer